Literature DB >> 30822291

Effects of Aerobic and Resistance Exercise on Cardiovascular Parameters for People Living With HIV: A Meta-analysis.

Philipp Zech, Camilo Pérez-Chaparro, Felipe Schuch, Bernd Wolfarth, Michael Rapp, Andreas Heissel.   

Abstract

People living with HIV (PLWH) have limited exercise capacity because of anemia, neuromuscular disorders, and pulmonary limitations. We used a meta-analysis to examine the effect of aerobic and resistance exercise alone and in combination on cardiovascular parameters. Subgroup meta-analyses were conducted and long-term effects of exercise were investigated. A systematic literature search was conducted up to July/August 2017. The Physiotherapy Evidence Database-scale was used to rate quality and assess the risk of bias on the papers. Standardized mean differences (SMDs) were calculated to assess the effect of exercise. Posttreatment comparison between the exercise and control groups revealed moderate and large effect sizes in favor of the intervention group for VO2max (SMD = 0.66, p < .0001) and the 6-minute walk test (SMD = 1.11, p = .0001). Exercise had a positive effect on cardiovascular parameters in PLWH. Exercise can be a prevention factor for PLWH dealing with multiple comorbidities.

Entities:  

Mesh:

Year:  2019        PMID: 30822291     DOI: 10.1097/JNC.0000000000000006

Source DB:  PubMed          Journal:  J Assoc Nurses AIDS Care        ISSN: 1055-3290            Impact factor:   1.354


  2 in total

1.  The Acute Effect of a Single Resistance Training Session on the Glycemic Response among Women with HIV/AIDS.

Authors:  Dayane C Souza; Pollyana M Nunhes; Wagner J R Domingues; Kauana Marchini; Lucas Hey; Jairo A Berti; Michele C C Trindade; Ademar Avelar
Journal:  Int J Exerc Sci       Date:  2020-02-01

Review 2.  Effects of Physical Activity Interventions on Health Outcomes among Older Adults Living with HIV: A Systematic Review and Meta-Analysis.

Authors:  Mi-So Shim; Dabok Noh
Journal:  Int J Environ Res Public Health       Date:  2022-07-11       Impact factor: 4.614

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.